Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2005-12-27
2005-12-27
Levy, Neil S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S001290, C424S001330, C424S647000, C424S648000, C424S493000, C424S497000, C514S502000
Reexamination Certificate
active
06979466
ABSTRACT:
The invention relates to nanoscale particles suited especially for use in tumor therapy by hyperthermia. Said particles comprise a (preferably superparamagnetic) iron oxide-containing core and at least two shells surrounding said core. The (innermost) shell adjoining the core is an envelope which comprises groups capable of forming cationic groups and is broken down by human or animal tissue at such a slow rate as to allow for association of the core surrounded by said envelope with the surface of cells and/or for absorption of said core into the inside of cells. The outer shell(s) consist(s) of species having neutral and/or anionic groups which allow the nanoscale particles to appear to the outside as having a neutral or negative charge and which are broken down by human or animal tissue more rapidly than the innermost shell—and in so doing uncover the shells underneath—but still sufficiently slowly so as to ensure that the nanoscale particles are adequately distributed in a tissue infiltrated with same particles in a particular point.
REFERENCES:
patent: 5034145 (1991-07-01), Leising et al.
patent: 5460831 (1995-10-01), Kossovsky et al.
patent: 5462751 (1995-10-01), Kossovsky et al.
patent: 5547748 (1996-08-01), Ruoff et al.
patent: 5616311 (1997-04-01), Yen
patent: 5922537 (1999-07-01), Ewart et al.
patent: 6022500 (2000-02-01), John et al.
patent: 6045821 (2000-04-01), Garrity et al.
patent: 6103379 (2000-08-01), Margel et al.
patent: 6541039 (2003-04-01), Lesniak et al.
patent: 196 14 136 (1997-10-01), None
patent: 0 472 990 (1995-06-01), None
patent: 0 667 148 (1995-08-01), None
patent: WO 90/01295 (1990-02-01), None
patent: WO 93/24076 (1993-12-01), None
patent: WO 88/00060 (1998-01-01), None
P. Hermentin et al., “Hinge-thiol coupling of monoclonal antibody to silanized iron oxide particles and evaluation of magnetic cell depletion”,Bioconjugate Chem., 1(6), 411-418 (1990).
C.W. Jung and P. Jacobs, “Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxide, ferumoxtran, ferumoxsil”,Magn. Reson. Imaging, 13(5), 661-674 (1995).
Jordan Andreas
Lesniak Christoph
Schiestel Thomas
Schmidt Helmut
Greenblum & Bernstein P.L.C.
Leibniz-Institut fuer neue Materialien Gemeinnuetzige GmbH
Levy Neil S.
LandOfFree
Nanoscale particles having an iron oxide-containing core... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanoscale particles having an iron oxide-containing core..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoscale particles having an iron oxide-containing core... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3494383